This inventor holds 1 USPTO granted patent. Top assignee: Alfa Wassermann, Inc.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Innovations by Ungarelli Fabrizio
Introduction
Ungarelli Fabrizio is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of new derivatives of heparin and heparan sulfate. His work focuses on enhancing the biological properties of these compounds while minimizing adverse effects.
Latest Patents
Fabrizio holds a patent for "Semi-synthetic glycosaminoglycans containing .alpha.-L-galacturonic acid." This innovation involves the creation of new heparin and heparan sulfate derivatives that possess antithrombotic activity. These derivatives are characterized by reduced hemorrhagic and anticoagulant activity, achieved through a structural modification that replaces the hydroxyl group in position 3 with a nucleophilic residue. This modification improves the biological properties of heparin and heparan sulfate while maintaining their therapeutic efficacy.
Career Highlights
Fabrizio is currently employed at Alfa Wassermann, Inc., where he continues to advance his research in glycosaminoglycans. His work has been instrumental in developing safer and more effective anticoagulant therapies. He has a total of 1 patent to his name, showcasing his innovative contributions to the field.
Collaborations
Fabrizio has collaborated with notable colleagues such as Piani Silvano and Tamagnone Gianfranco. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their projects.
Conclusion
Ungarelli Fabrizio's work exemplifies the intersection of innovation and practical application in biochemistry. His contributions to the development of safer anticoagulant therapies highlight the importance of ongoing research in this critical field.